Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Sales | 226,580 | 0 | 0 | 0 | 0 |
| Gross Profit | 226,580 | N/A | N/A | N/A | N/A |
| Operating Expenses | 101,057 | 45,512 | 13,115 | 0 | 0 |
| Operating Income | 125,522 | -45,512 | -13,115 | N/A | N/A |
| Other Income | 4,064 | -85 | -170 | 0 | 0 |
| Pre-tax Income | 129,586 | -45,597 | -13,285 | 0 | 0 |
| Income Tax | 31,293 | 306 | 88 | N/A | N/A |
| Net Income Continuous | 98,293 | -45,903 | -13,373 | N/A | N/A |
| Net Income | $98,293 | $-45,903 | $-13,373 | $N/A | $N/A |
| EPS Basic Total Ops | 1.04 | -0.62 | -0.34 | N/A | N/A |
| EPS Basic Continuous Ops | 1.04 | -0.62 | -0.34 | N/A | N/A |
| EPS Diluted Total Ops | 1.02 | -0.62 | -0.34 | N/A | N/A |
| EPS Diluted Continuous Ops | 1.02 | -0.62 | -0.34 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 1.02 | -0.62 | N/A | N/A | N/A |
| EBITDA(a) | $124,964 | $-45,500 | $-13,110 | $N/A | $N/A |